130 related articles for article (PubMed ID: 28873450)
1. Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.
Yokota T; Omachi K; Suico MA; Kojima H; Kamura M; Teramoto K; Kaseda S; Kuwazuru J; Shuto T; Kai H
PLoS One; 2017; 12(9):e0183959. PubMed ID: 28873450
[TBL] [Abstract][Full Text] [Related]
2. STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model.
Yokota T; Omachi K; Suico MA; Kamura M; Kojima H; Fukuda R; Motomura K; Teramoto K; Kaseda S; Kuwazuru J; Takeo T; Nakagata N; Shuto T; Kai H
Nephrol Dial Transplant; 2018 Feb; 33(2):214-223. PubMed ID: 28992339
[TBL] [Abstract][Full Text] [Related]
3. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.
Omachi K; Miyakita R; Fukuda R; Kai Y; Suico MA; Yokota T; Kamura M; Shuto T; Kai H
Clin Exp Nephrol; 2017 Dec; 21(6):952-960. PubMed ID: 28176019
[TBL] [Abstract][Full Text] [Related]
5. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
[TBL] [Abstract][Full Text] [Related]
7. Mild electrical stimulation and heat shock ameliorates progressive proteinuria and renal inflammation in mouse model of Alport syndrome.
Koga T; Kai Y; Fukuda R; Morino-Koga S; Suico MA; Koyama K; Sato T; Shuto T; Kai H
PLoS One; 2012; 7(8):e43852. PubMed ID: 22937108
[TBL] [Abstract][Full Text] [Related]
8. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
9. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
[TBL] [Abstract][Full Text] [Related]
10. Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome.
Andrews KL; Mudd JL; Li C; Miner JH
Am J Pathol; 2002 Feb; 160(2):721-30. PubMed ID: 11839593
[TBL] [Abstract][Full Text] [Related]
11. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.
Gross O; Girgert R; Beirowski B; Kretzler M; Kang HG; Kruegel J; Miosge N; Busse AC; Segerer S; Vogel WF; Müller GA; Weber M
Matrix Biol; 2010 Jun; 29(5):346-56. PubMed ID: 20307660
[TBL] [Abstract][Full Text] [Related]
12. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
[TBL] [Abstract][Full Text] [Related]
13. Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy.
Beirowski B; Weber M; Gross O
J Am Soc Nephrol; 2006 Jul; 17(7):1986-94. PubMed ID: 16775036
[TBL] [Abstract][Full Text] [Related]
14. Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease.
Meehan DT; Delimont D; Cheung L; Zallocchi M; Sansom SC; Holzclaw JD; Rao V; Cosgrove D
Kidney Int; 2009 Nov; 76(9):968-76. PubMed ID: 19710627
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated Expression of microRNA-21 and Disease-Related Genes in Human Patients and in a Mouse Model of Alport Syndrome.
Guo J; Song W; Boulanger J; Xu EY; Wang F; Zhang Y; He Q; Wang S; Yang L; Pryce C; Phillips L; MacKenna D; Leberer E; Ibraghimov-Beskrovnaya O; Ding J; Liu S
Hum Gene Ther; 2019 Jul; 30(7):865-881. PubMed ID: 30808234
[TBL] [Abstract][Full Text] [Related]
16. X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage.
Clark SD; Nabity MB; Cianciolo RE; Dufek B; Cosgrove D
PLoS One; 2016; 11(12):e0168343. PubMed ID: 27959966
[TBL] [Abstract][Full Text] [Related]
17. Epidermal basement membrane alpha 5(IV) expression in females with Alport syndrome and severity of renal disease.
Massella L; Onetti Muda A; Faraggiana T; Bette C; Renieri A; Rizzoni G
Kidney Int; 2003 Nov; 64(5):1787-91. PubMed ID: 14531812
[TBL] [Abstract][Full Text] [Related]
18. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
[TBL] [Abstract][Full Text] [Related]
19. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
[TBL] [Abstract][Full Text] [Related]
20. The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model.
Sannomiya Y; Kaseda S; Kamura M; Yamamoto H; Yamada H; Inamoto M; Kuwazuru J; Niino S; Shuto T; Suico MA; Kai H
Ren Fail; 2021 Dec; 43(1):510-519. PubMed ID: 33706638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
